临床分期IA≤2cm的非小细胞肺癌患者,单节段与多节段切除后的局部复发率和生存率均相等。

IF 3.1 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow
{"title":"临床分期IA≤2cm的非小细胞肺癌患者,单节段与多节段切除后的局部复发率和生存率均相等。","authors":"Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow","doi":"10.1093/ejcts/ezaf082","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small-cell lung cancer.</p><p><strong>Methods: </strong>A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤2 cm non-small-cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumours, small-cell lung cancer, underwent wedge resection or lobectomy. The primary outcome was locoregional recurrence. Secondary outcomes of disease-free survival, locoregional recurrence-free survival, overall survival, pathologic upstaging and perioperative complications were evaluated.</p><p><strong>Results: </strong>One hundred ninety (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumours (1.3 vs 1.45 cm, P = 0.02), but no significant difference in margin length (1.7 vs 2 cm, P = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, P < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, P = 0.03) was observed compared with multi-segment resection. Nevertheless, locoregional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (P = 0.72). With a median follow-up duration of 40 months, 5-year disease-free survival, locoregional recurrence-free survival and overall survival was 73, 89 and 87% following single-segment resection compared to 78, 95 and 84% after multi-segment resection.</p><p><strong>Conclusions: </strong>For patients with clinical stage IA non-small cell lung cancers ≤2 cm, locoregional recurrence and survival are not different based on whether patients receive a single-segment or multi-segment resection.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer.\",\"authors\":\"Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow\",\"doi\":\"10.1093/ejcts/ezaf082\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small-cell lung cancer.</p><p><strong>Methods: </strong>A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤2 cm non-small-cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumours, small-cell lung cancer, underwent wedge resection or lobectomy. The primary outcome was locoregional recurrence. Secondary outcomes of disease-free survival, locoregional recurrence-free survival, overall survival, pathologic upstaging and perioperative complications were evaluated.</p><p><strong>Results: </strong>One hundred ninety (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumours (1.3 vs 1.45 cm, P = 0.02), but no significant difference in margin length (1.7 vs 2 cm, P = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, P < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, P = 0.03) was observed compared with multi-segment resection. Nevertheless, locoregional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (P = 0.72). With a median follow-up duration of 40 months, 5-year disease-free survival, locoregional recurrence-free survival and overall survival was 73, 89 and 87% following single-segment resection compared to 78, 95 and 84% after multi-segment resection.</p><p><strong>Conclusions: </strong>For patients with clinical stage IA non-small cell lung cancers ≤2 cm, locoregional recurrence and survival are not different based on whether patients receive a single-segment or multi-segment resection.</p>\",\"PeriodicalId\":11938,\"journal\":{\"name\":\"European Journal of Cardio-Thoracic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-03-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cardio-Thoracic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ejcts/ezaf082\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cardio-Thoracic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejcts/ezaf082","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

目的:比较临床分期IA1和IA2非小细胞肺癌患者单节段和多节段切除的肿瘤预后。方法:使用前瞻性维护的数据库进行回顾性研究(2011-2022)。临床分期IA≤2 cm的非小细胞肺癌患者接受解剖节段切除术。患者分为单节段切除和多节段切除。排除患有神经内分泌肿瘤、小细胞肺癌、行楔形切除术或肺叶切除术的患者。主要结果为局部-区域复发。评估无病生存、局部-区域无复发生存、总生存、病理分期和围手术期并发症的次要结局。结果:单节段切除190例(63.8%),多节段切除108例(36.2%)。单节段切除组肿瘤较小(1.3 vs 1.45 cm, p = 0.02),切缘长度差异无统计学意义(1.7 vs 2 cm, p = 0.15)。结论:对于临床期≤2 cm的IA期非小细胞肺癌患者,无论是单节段切除还是多节段切除,局部区域复发率和生存率均无差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer.

Objectives: Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small-cell lung cancer.

Methods: A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤2 cm non-small-cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumours, small-cell lung cancer, underwent wedge resection or lobectomy. The primary outcome was locoregional recurrence. Secondary outcomes of disease-free survival, locoregional recurrence-free survival, overall survival, pathologic upstaging and perioperative complications were evaluated.

Results: One hundred ninety (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumours (1.3 vs 1.45 cm, P = 0.02), but no significant difference in margin length (1.7 vs 2 cm, P = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, P < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, P = 0.03) was observed compared with multi-segment resection. Nevertheless, locoregional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (P = 0.72). With a median follow-up duration of 40 months, 5-year disease-free survival, locoregional recurrence-free survival and overall survival was 73, 89 and 87% following single-segment resection compared to 78, 95 and 84% after multi-segment resection.

Conclusions: For patients with clinical stage IA non-small cell lung cancers ≤2 cm, locoregional recurrence and survival are not different based on whether patients receive a single-segment or multi-segment resection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
11.80%
发文量
564
审稿时长
2 months
期刊介绍: The primary aim of the European Journal of Cardio-Thoracic Surgery is to provide a medium for the publication of high-quality original scientific reports documenting progress in cardiac and thoracic surgery. The journal publishes reports of significant clinical and experimental advances related to surgery of the heart, the great vessels and the chest. The European Journal of Cardio-Thoracic Surgery is an international journal and accepts submissions from all regions. The journal is supported by a number of leading European societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信